Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for LENSAR, Inc. (LNSR : NSDQ)

• Company Description    LENSAR Inc. is a commercial-stage medical device company. It focuses on designing, developing and marketing an advanced femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. LENSAR Inc. is based in Orlando, Florida. Number of Employees: 110

• Price / Volume Information    Yesterday's Closing Price: $7.13 Daily Weekly Monthly 20 Day Moving Average: 9,139 shares Shares Outstanding: 10.98 (millions) Market Capitalization: $78.32 (millions) Beta: -0.20 52 Week High: $8.98 52 Week Low: $5.50 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -7.40% 1.05% 12 Week 20.85% 27.23% Year To Date 19.03% 38.75%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 2800 Discovery Drive - Orlando,FL 32826 USA ph: 888-536-7271 fax: - ir.contact@lensar.com http://www.lensar.com

• General Corporate Information    Officers Nicholas T. Curtis - Chief Executive Officer and Director William J. Link - Chairperson of the Board of Directors Thomas R. Staab, II - Chief Financial Officer Richard L. Lindstrom - Director John P. McLaughlin - Director Peer Information LENSAR, Inc. (ABMD) LENSAR, Inc. (DMDS) LENSAR, Inc. (CPWY.) LENSAR, Inc. (EQUR) LENSAR, Inc. (ECIA) LENSAR, Inc. (FMS) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED INSTRUMENTS Sector: Medical CUSIP: 52634L108 SIC: 3841 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/22 Next Expected EPS Date: 08/04/22 Share - Related Items Shares Outstanding: 10.98 Most Recent Split Date: (:1) Beta: -0.20 Market Capitalization: $78.32 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.68 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-2.46 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/04/22

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 1.57 Price/Cash Flow: - Price / Sales: 2.13 EPS Growth vs. Year Ago Period: -19.64% vs. Previous Quarter: -63.41% Sales Growth vs. Year Ago Period: 32.61% vs. Previous Quarter: -16.77% ROE 03/31/22 - -37.77 12/31/21 - -32.96 09/30/21 - -36.01 ROA 03/31/22 - -31.56 12/31/21 - -27.94 09/30/21 - -30.73 Current Ratio 03/31/22 - 4.97 12/31/21 - 5.14 09/30/21 - 5.81 Quick Ratio 03/31/22 - 4.41 12/31/21 - 4.40 09/30/21 - 4.55 Operating Margin 03/31/22 - -57.39 12/31/21 - -56.88 09/30/21 - -71.47 Net Margin 03/31/22 - -57.39 12/31/21 - -56.88 09/30/21 - -71.47 Pre-Tax Margin 03/31/22 - -57.39 12/31/21 - -56.88 09/30/21 - -71.47 Book Value 03/31/22 - 4.53 12/31/21 - 5.01 09/30/21 - 5.21 Inventory Turnover 03/31/22 - 2.17 12/31/21 - 1.58 09/30/21 - 1.19 Debt-to-Equity 03/31/22 - 0.00 12/31/21 - 0.00 09/30/21 - 0.00 Debt-to-Capital 03/31/22 - 0.00 12/31/21 - 0.00 09/30/21 - 0.00

Powered by Zacks Investment Research ©